News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Conference News AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab November 13, 2011